Sponsored by Ultragenyx Pharmaceutical Inc.
Variant ID | 524 |
---|---|
Genomic Coordinate (GRCh38) | g.22212915G>T |
Variant | c.1657G>T |
Variant Start Position | 1657 |
Location | Exon 16 |
Amino Acid Change | p.Gly553* |
ACMG Call | - |
ACMG Call Last Revised Date | 4/28/2021 |
Predicted ACMG Call | Pathogenic | Effect Type | Nonsense |
Variant Type | SNV |
PMID | 26377240, 34806794 |
Article Count | 2 |
Times Observed | < 3 |
Clinical Phenotype | - |
ACMG Categories | pvs1, pm2, pp1 |
ACMG Explanations | pvs1: This is a loss of function variant. pm2: chrX:22231032 ref:G alt:T was not found in gnomAD exomes or genomes. |
Variant in Clinvar | No |
ClinVar Classification | - |
Categories In Literature | pp1 |
No Contrary Evidence Found | Yes |
ExAC Allele Frequency | - |
Thousand Genomes Allel Frequency | - |
Ontology Relations | - |
hg19 Mapping Failed | No |
Literature Alleles | X-22231032-G-T |
GnomAD Alleles | - |
DBNSFP Alleles | X-22231032-G-T |
Other Alleles | X-22231032-GGA-TAG X-22231032-GG-TA |
Note | nan |
Warnings | - |